Advertisement

Topics

Addendum: The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease

09:09 EDT 22 Jun 2017 | Nature Publishing

Nature537, 50–56 (2016); doi:10.1038/nature19323Figure 1 of our original Article illustrated that treatment with aducanumab reduced human brain amyloid-β plaques in a dose-dependent fashion as measured by florbetapir positron emission tomography (PET) imaging. The figure gave the

Original Article: Addendum: The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease

NEXT ARTICLE

More From BioPortfolio on "Addendum: The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...